Biofilm and device infection
Objective: describe the biofilm cycle, explain why antibiotics and phagocytes fail against it, and why an infected device often has to be removed.
- Pathogen
- Structure
- Antibiotic
- Host (cells, tissues)
- Clinical consequence
Key points
- Cycle: adhesion, microcolonies, maturation within a matrix, dispersal.
- The matrix slows antibiotics and phagocytes; persisters tolerate without being mutants.
- Device infection: removal is often needed to cure.
Classic pitfall
Mistaking biofilm tolerance for genetic resistance: the free-living strain may test “susceptible” while treatment fails.
Related pathogen pages (7)
Sources
- Sharma D, Misba L, Khan AU — Antibiotics versus biofilm: an emerging battleground in microbial communities (Antimicrob Resist Infect Control) (2019)
- Balaban NQ et al. — Definitions and guidelines for research on antibiotic persistence (Nat Rev Microbiol) (2019)
- Donlan RM & Costerton JW — Biofilms: survival mechanisms of clinically relevant microorganisms (Clin Microbiol Rev) (2002)
- Mermel LA et al. — IDSA clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update (Clin Infect Dis) (2009)